Role of Lipidomic Signatures in Prognostication of Breast Cancer - A Pilot Study
European journal of surgical oncology(2023)
摘要
Introduction: Lipid reprogramming has a major attribution to rewiring of the oncogenic signalling pathways during onset and progression of cancer as well as establishing crosstalk between cancer cells and tumour microenvironment. Therefore, sphingolipids can provide breast cancer (BC) subtype- and stage-specific signatures/biomarkers that can help in prognosis, and prediction of the treatment outcome for subtypes like TNBC and luminal.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要